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INTRODUCTION
• At least 71 million individuals worldwide suffer from chronic 
hepatitis C virus (HCV) infection (1)
• This infection can cause fibrosis, cirrhosis, and ultimately 
hepatocellular carcinoma (HCC) due to the chronic inflammatory 
response
• IL-33 is a cytokine and nuclear factor implicated in numerous 
inflammatory and fibrotic diseases (2) including HCC (3)
• The role of IL-33 in HCV infection and HCV-mediated HCC is 
unknown, as is the mechanism behind the malignant transformation
MATERIALS/METHODS
Samples: Study was conducted on paraffin-embedded human liver 
tissues from the NIH Liver Tissue and Cell Distribution System with IRB 
approval
• Male end-stage liver disease patients with either HCV/cirrhosis (N=7) 
or HCV/HCC (N=7) were selected if they had no coinfection with HBV 
or HIV and no history of drug or alcohol abuse
• Normals were patients with no HCV or HCC diagnosis (N=6)
IHC: We performed immunohistochemistry (IHC) according to standard 
protocol. We used a nonenzymatic approach for antigen retrieval. We 
used human IL-33 as our primary antibody (R and D Systems AF3625) 
and anti-goat IgG as our secondary antibody (ImmPress Reagent Kit 
MP-7405). The tissues were stained with DAB (Vector Labs ImmPACT
DAB kit SK-4105 ) and counterstained with hematoxylin
Image Analysis: Protein positive staining and cellular localization were 
observed at 20X objective with the Nikon Eclipse Ts2R camera and the 
NIS Elements Basic Research Software. MATLAB was used (4) to analyze 
all images and provide an accurate quantification of IL-33 signal 
strength in energy units/pixel
Statistical Analysis: Data obtained from image analysis were analyzed 
statistically using GraphPad Prism software v7.04. Statistical 
significance between appropriate groups was determined by the non-
parametric Kruskall-Wallis test. Post-hoc analysis was performed using 
Dunn’s multiple comparisons test
OBJECTIVES
• Confirm the presence of IL-33 in human liver tissues
• Determine the cellular location of IL-33 expression 
• We hypothesized that IL-33 expression is altered in patients with 
HCV/cirrhosis and HCV/HCC as compared to normals
• IL-33 is expressed in human hepatocytes and portal 
areas
• Differential nuclear expression of IL-33 seems to be 
correlated with worsening disease state 
• IL-33 expression as measured by energy units/pixel is 
different according to disease state
Study was supported by OSU-CHS OK Stars program (Kelly 
McCracken and Dr. Nedra Wilson) and Cancer Sucks, 
Bixby, Oklahoma. Liver tissues obtained from NIH Liver 
Tissue and Cell Distribution System (LICDS; Contract No. 
HHSN276201200017C).
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RESULTS
• IL-33 expression was found in human hepatocytes (Figure 1A-C) and in the portal area (Figure 
1D-F) across all patients groups
• All normal patients (N=6) showed nuclear expression of IL-33 compared to 57% (N=4/7) 
HCV/cirrhosis and 29% (N=2/7) HCV/HCC patients
• As compared to normal tissue, IL-33 expression in hepatocytes was increased in HCV/cirrhosis 
patients and slightly decreased in HCV/HCC patients (Figure 2)
• In the portal area, IL-33 expression was similar across all patient groups (Figure 3)
Figure 2: IL-33 Expression in 
Hepatocytes
Figure 3: IL-33 Expression in Portal Area
Figure 1: Immunohistochemical staining of IL-33 in human liver tissues (40X 
objective) HCV/Cirrhosis
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White arrows indicate nuclei; black arrows indicate bile ducts
